Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant

Details for Australian Patent Application No. 2010333588 (hide)

Owner Protein Design Lab, Ltd.

Inventors Qiu, Xiaoqing

Agent Shelston IP

Pub. Number AU-A-2010333588

PCT Pub. Number WO2011/072501

Priority 200910242838.0 17.12.09 CN

Filing date 26 February 2010

Wipo publication date 23 June 2011

International Classifications

C07K 19/00 Hybrid peptides

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

C07K 14/245 Peptides having more than 20 amino acids

C12N 15/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/072501 Priority application(s): WO2011/072501

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010333645-Parabolic collector

2010333574-Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof